Ikarian Capital »

Solid Biosciences shares owned by Ikarian Capital

Quarter-by-quarter ownership of Solid Biosciences (SLDB) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Solid Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Solid Biosciences held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solid Biosciences by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 300k 4.00
2024-09-30 $2.1M 300k 6.97

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Solid Biosciences

Perceptive Advisors
RA Capital Management
Bain Capital Life Sciences Investors
Vestal Point Capital
Siren
BlackRock
Adage Capital Partners GP
Vanguard Group
ADAR1 Capital Management
Citadel Advisors
Finepoint Capital
Jpmorgan Chase & Co
Millennium Management
Redmile Group
Geode Capital Management

View all funds holding Solid Biosciences